Alphabet Is A Massive Cash Flow Machine With An Under-Leveraged Balance Sheet: Analyst
WestPark Capital analyst Curtis Shauger initiated coverage on Alphabet (NASDAQ:GOOG) on Tuesday with a Buy rating and a price ...
Alphabet: Leading The AI Race
Alphabet’s Gemini 2.5 Pro sets new AI benchmarks, powered by DeepMind and custom TPUs. Learn why GOOG stock offers long-term ...
Fierce Biotech1 天
Alphabet's AI biotech Isomorphic Labs hauls in $600M to power next-gen drug design model
AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...
Alphabet-backed Isomorphic Labs bags $600 million funding to build next-gen AI drug design ...
Isomorphic Labs is raising money in its first-ever external funding round from Thrive Capital, a big backer of ChatGPT ...
BioPharma Dive1 天
Isomorphic raises $600M on big ambitions for AI drugmaking tech
The drug discovery company, which has partnerships with Eli Lilly and Novartis, is developing AI models to design drugs and ...
Is Alphabet Stock Going to $210? One Wall Street Analyst Thinks So.
Despite the drop, Blackledge is still very bullish on Alphabet, and he left his buy recommendation intact. And why shouldn't he? Even at that reduced price target, the anticipated upside is over 30% ...
Google-backed AI drug discovery startup raises $600 million
Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ever external funding round led by Thrive Capital, the startup said on Monday.
Alphabet Inc. (GOOG): Quant Hedge Fund’s Signals Say “Buy, Buy, Buy”
We recently published a list of Top 10 Stocks to Buy According to Two Sigma Investments. In this article, we are going to ...
Harvard Business Review13 天
Alphabet CEO on AI as a Workplace Collaborator
Sundar Pichai is the CEO of Google as well as its parent company Alphabet, which he’s led as an AI-first company for several years. He speaks with HBR Editor at Large Adi Ignatius about shaping ...